Total Liabilities for Moderna (MRNA)
According to Moderna's latest reported financial statements, the company's latest reported total liabilities is $3.69B USD. Total liabilities sum everything the company owes at the end of each reporting period — accounts payable, accrued expenses, debt, lease obligations, and other claims — as filed on the balance sheet. Compare with total assets and net assets for solvency context.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
MRNA
Currently viewingTotal LiabilitiesSwitch metric
Latest period
$3.69B
YoY change
+13.8%
5Y CAGR
-5.0%
Peak year (2021)
$10.52B
Latest annual
$3.69B
Total Liabilities history chart for Moderna (MRNA) from 2016 to 2025
Total Liabilities history table for Moderna (MRNA) from 2016 to 2025
| Fiscal year | Period ended | Reported | Total Liabilities | YoY |
|---|---|---|---|---|
| 2025 | $3.69B | +13.8% | ||
| 2024 | $3.24B | -29.1% | ||
| 2023 | $4.57B | -32.1% | ||
| 2022 | $6.74B | -36.0% | ||
| 2021 | $10.52B | +120.4% | ||
| 2020 | $4.78B | +1051.9% | ||
| 2019 | $414.61M | -4.0% | ||
| 2018 | $431.91M | -5.9% | ||
| 2017 | $459.19M | -20.2% | ||
| 2016 | $575.31M | — |
Total Liabilities values are taken from Moderna's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, Moderna (MRNA) reported total liabilities of $3.69B – grew 13.8% year-over-year.
Through 2020–2025 (5 years), Moderna total liabilities delivered a -5.0% annualised rate; with a net decline across the window.
2021 marks the peak total liabilities at $10.52B, with the historical low of $414.61M recorded in 2019.
Moderna (MRNA) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $101.80B.
Moderna Total Liabilities by Year
Moderna Total Liabilities 2025: $3.69B
Moderna total liabilities in 2025 was $3.69B, grew 13.8% from 2024.
Moderna Total Liabilities 2024: $3.24B
Moderna total liabilities in 2024 was $3.24B, declined 29.1% below 2023.
Moderna Total Liabilities 2023: $4.57B
Moderna total liabilities in 2023 was $4.57B, plunged 32.1% below 2022.
Moderna Total Liabilities 2022: $6.74B
Moderna total liabilities in 2022 was $6.74B, plunged 36.0% below 2021.
Moderna Total Liabilities 2021: $10.52B
Moderna total liabilities in 2021 was $10.52B.
See more financial history for Moderna (MRNA).
Sector peers — Total Liabilities
Companies in the same sector as Moderna, ranked by their latest total liabilities.
| Company | Total Liabilities | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $348.86B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $207.88B | Healthcare |
| AbbVie Inc. (ABBV) | $137.19B | Healthcare |
| Johnson & Johnson (JNJ) | $117.67B | Healthcare |
| Eli Lilly and Company (LLY) | $85.94B | Healthcare |
| Merck & Co., Inc. (MRK) | $84.20B | Healthcare |
| Amgen Inc. (AMGN) | $81.93B | Healthcare |
| AstraZeneca PLC (AZN) | $65.36B | Healthcare |
Frequently asked questions
What is Moderna's total liabilities?
- Latest reported total liabilities for Moderna (MRNA) is $3.69B (period ending December 31, 2025).
How has Moderna total liabilities changed year-over-year?
- Moderna (MRNA) total liabilities changed +13.8% year-over-year on the latest annual filing.
What is the long-term growth rate of Moderna total liabilities?
- Moderna (MRNA) total liabilities compound annual growth rate is -5.0% over the most recent 5 years available.
When did Moderna total liabilities hit its highest annual value?
- Moderna total liabilities reached its highest annual value of $10.52B in 2021.
What was Moderna total liabilities in 2024?
- Moderna (MRNA) total liabilities in 2024 was $3.24B.
What was Moderna total liabilities in 2025?
- Moderna (MRNA) total liabilities in 2025 was $3.69B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
MRNA Overview
Company profile, financial tools, and key metrics
MRNA Revenue Counter
Earns $61.61 every second. See per minute, hour, and day.
MRNA Earnings Counter
Loses −$89.49 per second. See per minute, hour, and day.
MRNA Economic Scale
Exceeds Timor-Leste's GDP. Compare with world economies.
MRNA What If Invested
What if you had invested $1,000? See historical returns from any date.
MRNA How It Makes Money
Discover visual breakdown of $1.94B in revenue — where it comes from and where it goes.
MRNA Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
MRNA Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
MRNA Daily Price Character
Explosive · 48.2% historical win rate (green days). Streaks & record days.
MRNA Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.